UK markets open in 2 hours 22 minutes

GC Biopharma Corp. (006280.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
115,000.00-1,200.00 (-1.03%)
As of 01:17PM KST. Market open.
Currency in KRW
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2276
Avg. Estimate-197.56862,236.574,501
Low estimate-8045678343,652
High estimate4098053,8405,221
Year ago EPS-1,967155-2,3332,236.57
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5688
Avg. Estimate356.8M455.98M1.75B1.86B
Low estimate359M442.7M1.7B1.8B
High estimate390M470.8M1.78B1.93B
Year ago sales383.77MN/A1.63B1.75B
Sales growth (year/est)-7.00%N/A7.70%6.40%
Earnings history31/03/202330/06/202330/09/202331/12/2023
Est. EPS-76.141,343.962,425.93-433.5
Actual EPS-1,9671551,220-1,740
Difference-1,890.86-1,188.96-1,205.93-1,306.5
Surprise %-2,483.40%-88.50%-49.70%-301.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-197.56862,236.574,501
7 days ago-197.56861,969.334,393.2
30 days ago548.5884.52,135.674,314.6
60 days ago548.5884.52,375.294,314.6
90 days ago548.5884.52,0654,314.6
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates006280.KSIndustrySector(s)S&P 500
Current qtr.90.00%N/AN/AN/A
Next qtr.342.60%N/AN/AN/A
Current year195.90%N/AN/AN/A
Next year101.20%N/AN/AN/A
Next 5 years (per annum)-10.67%N/AN/AN/A
Past 5 years (per annum)-9.96%N/AN/AN/A